edaravone has been researched along with Aortic Aneurysm, Abdominal in 2 studies
Aortic Aneurysm, Abdominal: An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to define whether edaravone, a free-radical scavenger, influenced angiotensin II (AngII)-induced atherosclerosis and abdominal aortic aneurysms (AAAs) formation." | 8.12 | Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. ( Daugherty, A; Hada, Y; Shikata, K; Subramanian, V; Takatsuka, T; Takeuchi, H; Uchida, HA; Umebayashi, R; Wada, J, 2022) |
| "Edaravone treatment significantly reduced messenger RNA expressions of cytokines and matrix metalloproteinases (MMPs) in aneurysm walls (MMP-2: 1." | 5.38 | Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. ( Hasegawa, T; Morimoto, K; Morimoto, N; Okada, K; Okita, Y; Tanaka, A; Wulan, B; Yu, J, 2012) |
| "The aim of the study was to define whether edaravone, a free-radical scavenger, influenced angiotensin II (AngII)-induced atherosclerosis and abdominal aortic aneurysms (AAAs) formation." | 4.12 | Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. ( Daugherty, A; Hada, Y; Shikata, K; Subramanian, V; Takatsuka, T; Takeuchi, H; Uchida, HA; Umebayashi, R; Wada, J, 2022) |
| "Edaravone treatment significantly reduced messenger RNA expressions of cytokines and matrix metalloproteinases (MMPs) in aneurysm walls (MMP-2: 1." | 1.38 | Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. ( Hasegawa, T; Morimoto, K; Morimoto, N; Okada, K; Okita, Y; Tanaka, A; Wulan, B; Yu, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchida, HA | 1 |
| Takatsuka, T | 1 |
| Hada, Y | 1 |
| Umebayashi, R | 1 |
| Takeuchi, H | 1 |
| Shikata, K | 1 |
| Subramanian, V | 1 |
| Daugherty, A | 1 |
| Wada, J | 1 |
| Morimoto, K | 1 |
| Hasegawa, T | 1 |
| Tanaka, A | 1 |
| Wulan, B | 1 |
| Yu, J | 1 |
| Morimoto, N | 1 |
| Okita, Y | 1 |
| Okada, K | 1 |
2 other studies available for edaravone and Aortic Aneurysm, Abdominal
| Article | Year |
|---|---|
Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Atherosclero | 2022 |
Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antipyrine; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apop | 2012 |